Pubmed    Pubmed Central		uBio Home | uBioRSS
WebSearch Literature Molecular Images

uBio  Web  Results 11 - 20 of about 2417024 Scientific:    Epinephelus spilotoceps (Mur in ae en)     Naso hexacanthus (Ik in ae)  Synonyms:    Himantopus mexicanus (aeo)  Broader Terms:    Ciconiiformes (grebes)     Himantopus (stilts)     Recurvirostridae      Latest Articles on ae from uBioRSS Black-necked Stilt - Aves - Birds Photo Pool Himantopus mexicanus ForestryImages.org External Resources: Did you mean: a or or? 11.  Adverse health behaviours in long-term testicular cancer survivors: a Danish nationwide study. Kreiberg M, Bandak M, Lauritsen J, Wagner T, Rosenvilde J, Agerbaek M, Dysager L, Lau CJ, Andersen KK, Daugaard G Acta oncologica (Stockholm, Sweden), 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 12.  Phase 2 Study of the Safety and Efficacy of Umbralisib in Patients with CLL Who Are Intolerant to BTK or PI3K? Inhibitor Therapy. Mato AR, Ghosh N, Schuster SJ, Lamanna N, Pagel JM, Flinn IW, Barrientos J, Rai KR, Reeves JA, Cheson BD, Barr PM, Kambhampati S, Lansigan F, Pu JJ, Skarbnik AP, Roeker LE, Fonseca G, Sitlinger A, Hamadeh IS, Dorsey C, LaRatta N, Weissbrot H, Luning Prak ET, Tsao PY, Paskalis D, Sportelli P, Miskin HP, Weiss MS, Svoboda J, Brander DM Blood, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 13.  The effect of water hardness on atopic eczema and skin barrier function: A systematic review and meta-analysis. Jabbar-Lopez ZK, Ung CY, Alexander H, Gurung N, Chalmers J, Danby S, Cork MJ, Peacock JL, Flohr C Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 14.  Research Review: Developmental origins of depression - a systematic review and meta-analysis. Su Y, D'Arcy C, Meng X Journal of child psychology and psychiatry, and allied disciplines, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 15.  Induced Experimental Periimplantitis and Periodontitis: What are the Differences in the Inflammatory Response ? Huang H, Chen D, Lippuner K, Hunziker EB The Journal of oral implantology, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 16.  Effects of vitamin B12 supplementation on neurodevelopment and growth in Nepalese Infants: A randomized controlled trial. Strand TA, Ulak M, Hysing M, Ranjitkar S, Kvestad I, Shrestha M, Ueland PM, McCann A, Shrestha PS, Shrestha LS, Chandyo RK PLoS medicine, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 17.  Effect of different carbon dioxide (CO2) flows on trapping Aedes albopictus with BG traps in the field in Zhejiang Province, China. Wu Y, Wang J, Li T, Liu Q, Gong Z, Hou J PloS one, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 18.  Racial differences in patient-provider communication, patient self-efficacy, and their associations with lupus-related damage: a cross-sectional survey. Sun K, Eudy AM, Criscione-Schreiber LG, Sadun RE, Rogers JL, Doss J, Corneli AL, Bosworth HB, Clowse MEB The Journal of rheumatology, 2020 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 19.  Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. Wan Z, Sun R, Moharil P, Chen J, Liu Y, Song X, Ao Q Journal of leukocyte biology J Leukoc Biol Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. 10.1002/JLB.5MR0620-063RR In the past decade, clinical and laboratory studies have led to important new insights into the biology of leukemia and its treatment. This review describes the progress of leukemia research in the United States in recent years. Whereas the traditional method of treatment is chemotherapy, it is nonselective and could induce systemic toxicities. Thus, in parallel with research on new chemotherapies, great emphasis has been placed on developing immunotherapies. Here, we will review the current immunotherapies available in research and development that overcome current challenges, specifically looking in the field of chimeric antigen receptor T-cell (CAR-T) therapies, checkpoint inhibitors, and antibody-drug conjugates. With about 100 clinical trials for CAR-T therapies and 30 in checkpoint inhibitors for leukemia treatment, scientists are trying to make these technologies cheaper, faster, and more feasible. Further describing the delivery of these therapeutics, we look at the current progress, clinical, and preclinical status of nano-based medicines such as liposomes, polymeric micelles, and metal nanoparticles. Taking advantage of their physicochemical and biologic properties, nanoparticles have been shown to increase the efficacy of commonly administered chemotherapies with reduced adverse effects. ©2020 Society for Leukocyte Biology. Wan Zhuoya Z Institute of Regulatory Science for Medical Device, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China. Sun Runzi R Department of Immunology, School of Medicine, University of Pittsburgh, Pennsylvania, USA. Moharil Pearl P Department of Cell Biology, Harvard Medical School, Harvard University, Massachusetts, USA. Department of Pharmaceutical Science, School of Pharmacy, University of Pittsburgh, Pennsylvania, USA. Chen Jing J Institute of Regulatory Science for Medical Device, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China. Department of Pharmaceutical Science, School of Pharmacy, University of Pittsburgh, Pennsylvania, USA. Liu Yuzhe Y Department of Materials Engineering, Purdue University, Indiana, USA. Song Xu X Institute of Regulatory Science for Medical Device, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China. Ao Qiang Q https://orcid.org/0000-0001-6747-7100 Institute of Regulatory Science for Medical Device, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China. eng 2017YFA0105802 National Key R&D Program of China SQ2020YFF0426289 National Key R&D Program of China 2020YFH0008 Sichuan Science and Technology Program Journal Article Review 2020 08 17 United States J Leukoc Biol 8405628 0741-5400 IM     2020 03 31 2020 06 29 2020 07 12 2020 12 1 12 45 2020 12 2 6 0 2020 12 2 6 0 aheadofprint 33259068 10.1002/JLB.5MR0620-063RR